Anteris Technologies Global Corp

AVR

Company Profile

  • Business description

    Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV), was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis - a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow.

  • Contact

    9 Sherwood Road
    Level 3, Suite 302, Toowong Tower
    ToowongQLD4066
    AUS

    T: +61 1300550310

    https://www.anteristech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    108

Stocks News & Analysis

stocks

ASX shares plunge but remain undervalued

Shares drop 17% after guidance is revised but we still see value.
stocks

Ask the analyst: Why have markets shunned APA Group?

Australia's premier gas infrastructure firm used to be a market darling, but its shares have taken a severe de-rating in recent years.
stocks

The 10 best US dividend stocks

These undervalued stocks with reliable dividends are worth considering.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,543.7034.10-0.40%
CAC 407,431.0459.24-0.79%
DAX 4020,214.79102.31-0.50%
Dow JONES (US)41,938.45696.75-1.63%
FTSE 1008,248.4971.20-0.86%
HKSE19,064.29176.60-0.92%
NASDAQ19,161.63317.25-1.63%
Nikkei 22539,190.40414.69-1.05%
NZX 50 Index12,895.9847.76-0.37%
S&P 5005,827.0491.21-1.54%
S&P/ASX 2008,294.1035.10-0.42%
SSE Composite Index3,168.5242.87-1.33%

Market Movers